B+L/Novaliq Hope Miebo Can Stand Out In Crowded Dry Eye Field

Big Week For Bausch As Court Ruling Could Benefit Planned Spinoff

Bausch + Lomb and Novaliq announced the approval of Miebo in dry eye disease • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from New Products

More from Scrip